Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients [clinicaltrials:NCT00040651]
Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients [clinicaltrials:NCT00040651]
Bio2RDF identifier
NCT00040651
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00040651
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Scleroderma, or systemi ...... in patients with severe SSc.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Value of Self Bone ...... herapy in Scleroderma Patients
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2007-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
SSc is a chronic diseas ...... assess patients' health.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-07-05T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
Chemotherapy
Cyclophosphamide
Fludarabine
Leukapheresis
Scleroderma
Systemic Sclerosis
Thymoglobulin
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-12-19T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00040651
official title [clinicaltrials_vocabulary:official-title]
Transplantation With T-Cell De ...... Phase I Dose Escalation Study
org study id [clinicaltrials_vocabulary:org-study-id]
N01 AR92239
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2007-03-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-07-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-12-01T00:00:00Z
identifier
clinicaltrials:NCT00040651
title
Safety and Value of Self Bone ...... herapy in Scleroderma Patients
@en
type
label
Safety and Value of Self Bone ...... s [clinicaltrials:NCT00040651]
@en